225 related articles for article (PubMed ID: 21704809)
21. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.
Canto MI; Goggins M; Hruban RH; Petersen GM; Giardiello FM; Yeo C; Fishman EK; Brune K; Axilbund J; Griffin C; Ali S; Richman J; Jagannath S; Kantsevoy SV; Kalloo AN
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):766-81; quiz 665. PubMed ID: 16682259
[TBL] [Abstract][Full Text] [Related]
22. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL
Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754
[TBL] [Abstract][Full Text] [Related]
23. New strategies for the early detection of pancreatic cancer.
Petrone MC; Arcidiacono PG
Expert Rev Gastroenterol Hepatol; 2016; 10(2):157-9. PubMed ID: 26582179
[TBL] [Abstract][Full Text] [Related]
24. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis.
Varadarajulu S; Tamhane A; Eloubeidi MA
Gastrointest Endosc; 2005 Nov; 62(5):728-36; quiz 751, 753. PubMed ID: 16246688
[TBL] [Abstract][Full Text] [Related]
25. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
26. A prediction rule for estimating pancreatic cancer risk in chronic pancreatitis patients with focal pancreatic mass lesions with prior negative EUS-FNA cytology.
Cai QC; Chen Y; Xiao Y; Zhu W; Xu QF; Zhong L; Chen SY; Zhang MM; Wang LW; Li ZS
Scand J Gastroenterol; 2011 Apr; 46(4):464-70. PubMed ID: 21114434
[TBL] [Abstract][Full Text] [Related]
27. Serum CA 242: the search for a valid marker of pancreatic cancer.
Ventrucci M; Ubalducci GM; Cipolla A; Panella MA; Ligabue A
Clin Chem Lab Med; 1998 Mar; 36(3):179-84. PubMed ID: 9589807
[TBL] [Abstract][Full Text] [Related]
28. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
29. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions.
Frossard JL; Amouyal P; Amouyal G; Palazzo L; Amaris J; Soldan M; Giostra E; Spahr L; Hadengue A; Fabre M
Am J Gastroenterol; 2003 Jul; 98(7):1516-24. PubMed ID: 12873573
[TBL] [Abstract][Full Text] [Related]
30. CA 19-9 predicts resectability of pancreatic cancer even in jaundiced patients.
Santucci N; Facy O; Ortega-Deballon P; Lequeu JB; Rat P; Rat P
Pancreatology; 2018 Sep; 18(6):666-670. PubMed ID: 30153902
[TBL] [Abstract][Full Text] [Related]
31. Predicting factors for unresectability in patients with pancreatic ductal adenocarcinoma.
Okada K; Kawai M; Tani M; Hirono S; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):648-53. PubMed ID: 24764208
[TBL] [Abstract][Full Text] [Related]
32. Detection of KRAS gene mutations in endoscopic ultrasound-guided fine-needle aspiration biopsy for improving pancreatic cancer diagnosis.
Wang X; Gao J; Ren Y; Gu J; Du Y; Chen J; Jin Z; Zhan X; Li Z; Huang H; Lv S; Gong Y
Am J Gastroenterol; 2011 Dec; 106(12):2104-11. PubMed ID: 21876563
[TBL] [Abstract][Full Text] [Related]
33. Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma.
Chang JC; Kundranda M
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335509
[TBL] [Abstract][Full Text] [Related]
34. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration.
Krishna SG; Bhattacharya A; Ross WA; Ladha H; Porter K; Bhutani MS; Lee JH
J Gastroenterol Hepatol; 2015 Oct; 30(10):1552-60. PubMed ID: 25867963
[TBL] [Abstract][Full Text] [Related]
35. Strategies for screening for pancreatic adenocarcinoma in high-risk patients.
Canto MI
Semin Oncol; 2007 Aug; 34(4):295-302. PubMed ID: 17674957
[TBL] [Abstract][Full Text] [Related]
36. 18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma.
Nakata B; Chung YS; Nishimura S; Nishihara T; Sakurai Y; Sawada T; Okamura T; Kawabe J; Ochi H; Sowa M
Cancer; 1997 Feb; 79(4):695-9. PubMed ID: 9024707
[TBL] [Abstract][Full Text] [Related]
37. Value of Early Check-Up of Carbohydrate Antigen 19-9 Levels for Pancreatic Cancer Screening in Asymptomatic New-Onset Diabetic Patients.
Choe JW; Kim JS; Kim HJ; Hwang SY; Joo MK; Lee BJ; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT
Pancreas; 2016; 45(5):730-4. PubMed ID: 26646277
[TBL] [Abstract][Full Text] [Related]
38. Preoperative evaluation of pancreatic adenocarcinoma.
Parsons CM; Sutcliffe JL; Bold RJ
J Hepatobiliary Pancreat Surg; 2008; 15(4):429-35. PubMed ID: 18670846
[TBL] [Abstract][Full Text] [Related]
39. CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Tsavaris N; Kosmas C; Papadoniou N; Kopterides P; Tsigritis K; Dokou A; Sarantonis J; Skopelitis H; Tzivras M; Gennatas K; Polyzos A; Papastratis G; Karatzas G; Papalambros A
J Chemother; 2009 Dec; 21(6):673-80. PubMed ID: 20071292
[TBL] [Abstract][Full Text] [Related]
40. Recurrent pancreatic adenocarcinoma: spiral CT evaluation following the Whipple procedure.
Bluemke DA; Abrams RA; Yeo CJ; Cameron JL; Fishman EK
Radiographics; 1997; 17(2):303-13. PubMed ID: 9084073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
